Literature DB >> 21956364

Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.

Kazuhiro Kitajima1, Yoshiko Ueno, Tetsuo Maeda, Koji Murakami, Yasushi Kaji, Masato Kita, Kayo Suzuki, Kazuro Sugimura.   

Abstract

The purpose of this article is to review fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) and magnetic resonance imaging (MRI) findings in a variety of benign, malignant, and borderline malignant ovarian tumors. It is advantageous to become familiar with the wide variety of FDG-PET/CT findings of this entity. Benign ovarian tumors generally have faint uptake, whereas endometriomas, fibromas, and teratomas show mild to moderate uptake. Malignant ovarian tumors generally have intense uptake, whereas tumors with a small solid component often show minimal uptake.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956364     DOI: 10.1007/s11604-011-0610-x

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  11 in total

1.  Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer.

Authors:  Norbert Avril; Stefanie Sassen; Barbara Schmalfeldt; Joerg Naehrig; Stephan Rutke; Wolfgang A Weber; Martin Werner; Henner Graeff; Markus Schwaiger; Walther Kuhn
Journal:  J Clin Oncol       Date:  2005-09-12       Impact factor: 44.544

2.  The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

Authors:  Signe Risum; Claus Høgdall; Annika Loft; Anne K Berthelsen; Estrid Høgdall; Lotte Nedergaard; Lene Lundvall; Svend A Engelholm
Journal:  Gynecol Oncol       Date:  2007-01-16       Impact factor: 5.482

3.  Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.

Authors:  Seok-Ki Kim; Keon Wook Kang; Ju Won Roh; Jung Suk Sim; Eun Sook Lee; Sang-Yoon Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-17       Impact factor: 9.236

4.  Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.

Authors:  Eun Ji Nam; Mi Jin Yun; Young Taik Oh; Jae Wook Kim; Jae Hoon Kim; Sunghoon Kim; Yong Wook Jung; Sang Wun Kim; Young Tae Kim
Journal:  Gynecol Oncol       Date:  2009-11-18       Impact factor: 5.482

Review 5.  MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.

Authors:  Veena R Iyer; Susanna I Lee
Journal:  AJR Am J Roentgenol       Date:  2010-02       Impact factor: 3.959

6.  Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

7.  Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography.

Authors:  Yorito Yamamoto; Hiroyoshi Oguri; Ruriko Yamada; Nagamasa Maeda; Shino Kohsaki; Takao Fukaya
Journal:  Int J Gynaecol Obstet       Date:  2008-04-18       Impact factor: 3.561

8.  Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Domeki; Yasushi Kaji; Ichio Fukasawa; Noriyuki Inaba; Narufumi Suganuma; Kazuro Sugimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04-17       Impact factor: 9.236

9.  Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Kenji Kanenishi; Masami Ohno; Toshiyuki Hata; Yoshio Kushida; Reiji Haba; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-18       Impact factor: 9.236

10.  Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Authors:  Hedva Lerman; Ur Metser; Dan Grisaru; Ami Fishman; Gennady Lievshitz; Einat Even-Sapir
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.